Drugs that contain Metformin Hydrochloride; Repaglinide
1. Prandimet patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6677358 | NOVO NORDISK INC | NIDDM regimen |
Jun, 2018
(5 years ago) | |
Market Authorisation Date: 23 June, 2008
Treatment: Use of repaglinide in combination with metformin to lower blood glucose
Dosage: TABLET;ORAL
How can I launch a generic of PRANDIMET before it's drug patent expiration?
More Information on Dosage
PRANDIMET family patents
